CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-30 | Guse Kyle CFO, Gen Counsel and Secretary | Purchase · Warrants | +2,272 | $1,000.00 | $2.3M | 2,272 |
| 2017-11-15 | Guse Kyle CFO, Gen Counsel and Secretary | Purchase | +8,600 | $0.34 | $3K | 8,600 |
| 2017-11-15 | Guse Kyle CFO, Gen Counsel and Secretary | Purchase | +1,400 | $0.34 | $471 | 10,000 |
| 2017-05-24 | WEAVER GREGORY L Director | Grant or award · Stock Option (right to buy) | +54,949 | 69,917 | ||
| 2017-05-24 | Steinhart Richard I Director | Grant or award · Stock Option (right to buy) | +49,531 | 59,062 | ||
| 2017-05-24 | Remmel H. Lawrence Director | Grant or award · Stock Option (right to buy) | +57,685 | 75,369 | ||
| 2017-05-24 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +575,893 | 651,785 | ||
| 2017-05-24 | Guse Kyle CFO, Gen Counsel and Secretary | Grant or award · Stock Option (right to buy) | +495,333 | 640,667 | ||
| 2017-05-24 | Galli Stephen J Director | Grant or award · Stock Option (right to buy) | +64,132 | 88,263 | ||
| 2017-05-24 | Chen Shu-Chih Director | Grant or award · Stock Option (right to buy) | +60,202 | 80,404 | ||
| 2017-04-17 | Remmel H. Lawrence Director | Purchase | +2,500 | $0.63 | $2K | 3,126 |
| 2016-05-18 | Chen Shu-Chih Director | Grant or award · Stock Option (right to buy) | +151,516 | 151,516 | ||
| 2016-05-18 | Guse Kyle CFO, Gen Counsel and Secretary | Grant or award · Stock Option (right to buy) | +1,090,000 | 1,090,000 | ||
| 2016-05-18 | Galli Stephen J Director | Grant or award · Stock Option (right to buy) | +180,987 | 180,987 | ||
| 2016-05-18 | Steinhart Richard I Director | Grant or award · Stock Option (right to buy) | +71,484 | 71,484 | ||
| 2016-05-18 | WEAVER GREGORY L Director | Grant or award · Stock Option (right to buy) | +112,190 | 112,190 | ||
| 2016-05-18 | QUAY STEVEN C President & CEO | Grant or award · Common Stock (right to buy) | +569,194 | 569,194 | ||
| 2016-05-18 | Remmel H. Lawrence Director | Grant or award · Stock Option (right to buy) | +132,634 | 132,634 | ||
| 2016-04-01 | Remmel H. Lawrence Director | Purchase | +1,500 | $0.33 | $495 | 10,900 |
| 2016-03-09 | Chen Shu-Chih Director | Purchase | +15,000 | $0.37 | $6K | 4,348,315 |
Page 6 of 9 · 168 trades